Nova Mentis Life Science Corp. (CSE: NOVA)
Canada
· Delayed Price · Currency is CAD 0.0050
0.00 (0.00%)
Sep 23, 2024, 4:00 PM EDT
Nova Mentis Life Science Company Description
Nova Mentis Life Science Corp., through its subsidiaries, operates as a biotechnology company worldwide.
It engages in developing diagnostics and psilocybin-based therapeutics for the treatment of neuroinflammatory disorders, including autism spectrum disorder and fragile X syndrome.
The company was formerly known as Liberty Leaf Holdings Ltd. and changed its name to Nova Mentis Life Science Corp. in June 2020.
Nova Mentis Life Science Corp. was incorporated in 2004 and is based in Vancouver, Canada.
Nova Mentis Life Science Corp.
| Country | Canada |
| Founded | 2004 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | William Rascan |
Contact Details
Address: 700-838 West Hasting Street Vancouver, British Columbia V6C 0A6 Canada | |
| Phone | 778 819 0244 |
| Website | novamentis.ca |
Stock Details
| Ticker Symbol | NOVA |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CAD |
| ISIN Number | CA66980V1067 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| William Rascan | Chief Executive Officer |
| Rebecca Hudson | Chief Financial Officer |